Cyntia Tremblay
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
High molecular weight insoluble parkin in the substantia nigra of patients with idiopathic Parkinson's disease.
Journal: NPJ Parkinson's disease
Published: November 12, 2025
Plasma p-tau markers, vascular factors, and cognitive decline in the CIMA-Q cohort.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: October 01, 2025
Distinct alterations of adiponectin, fibroblast growth factor 21 (FGF-21), and insulin-like growth factor binding protein 2 (IGFBP-2) link dysmetabolism with cognitive decline across the Alzheimer's disease spectrum.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 16, 2025
Differences in blood levels of neuroligin-derived peptides in a cohort for early detection of Alzheimer's disease.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: August 01, 2025
Differences in blood levels of neuroligin-derived peptides in a cohort for early detection of Alzheimer's disease.
Journal: The journals of gerontology. Series A, Biological sciences and medical sciences
Published: August 01, 2025
Postmortem Fatty Acid Abnormalities in the Cerebellum of Patients with Essential Tremor.
Journal: Cerebellum (London, England)
Published: August 21, 2024
Differential impact of eicosapentaenoic acid and docosahexaenoic acid in an animal model of Alzheimer's disease.
Journal: Journal of lipid research
Published: June 24, 2024
Age-dependent impact of streptozotocin on metabolic endpoints and Alzheimer's disease pathologies in 3xTg-AD mice.
Journal: Neurobiology of disease
Published: March 26, 2024
Lower GLUT1 and unchanged MCT1 in Alzheimer's disease cerebrovasculature.
Journal: Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism
Published: March 05, 2024
Correction to: Higher angiotensin‑converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.
Journal: Acta neuropathologica communications
Published: November 02, 2023
Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.
Journal: Acta neuropathologica communications
Published: August 29, 2023
Additive neurorestorative effects of exercise and docosahexaenoic acid intake in a mouse model of Parkinson's disease.
Journal: Neural regeneration research
Published: April 13, 2023
Last Updated: 09/26/2026